Vinorelbine Completed Phase 2 Trials for Lymphoma, Large B-Cell, Diffuse (DLBCL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00842595Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas